InnoGen Upholds GMA Campaign On Low-Priced Quality Medicines

It is sad to note that when poor people get sick, many of them do not consult their doctors, unless it’s a free clinic or a medical mission. These people rely on free medicines and when they are given prescriptions, they don’t buy medicines either, because they are too poor. This had been the common situation in the Philippines today.

Aware of this In view of this, InnoGen Pharma Group, Inc. came out in full support to President Gloria Macapagal-Arroyo campaign to bring affordable and high-quality drugs and medicines to the poor in the capital region and the provinces to respond to their medical needs.

A study by the World Health Organization shows that only fewer than 30 percent of Filipinos have access to medicines, despite that there are more than 300 pharmaceutical firms in the country. Prices of some medicines are so high when sold in the Philippines than when they are sold in other Asian countries.

Here’s is good news for patients who are slowly being killed by high cost of medicines. InnoGen’s voice of support is not mere words, but is followed by action. It has launched low-priced and high-quality medicines as treatment of diseases commonly afflicting middle-aged and elderly persons. The common diseases are hypertension, cardiovascular, diabetes, neurology and nutritional supplements, among other ailments.

InnoGen has launched Amlodipine at P20.00 only, lower by one-half compared to other brands; Clopidogrel, at P120.00 only, lower by 50-percent than other brands. InnoGen has also brought down the prices of Gabapentin and Orlistat by 30-percent.

InnoGen Pharma Group has been here for some time now, serving the public without fanfare. The company has been working toward better drugs that are cost-effective, efficient, safe and of excellent quality.

Under the InnoGen Pharma Group, are nine divisions, assigned to manufacture specific therapeutic drugs in areas like: neurology, hypertension, cardio-metabolic, diabetes and pediatric.

The company provides second-to-innovator products, most of which are off-patent molecules. It established partnership with foreign-based giant pharmaceutical firms, giving way to the use of latest equipment and facilities.

We aim to become the leader in the industry in terms of service to the people, providing innovative, high-quality, safe and affordable medicines, that goes well with our slogan of “Valuing Life Through Innovations.”